---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-236782"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:32:37.470908+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma enters ATM sales agreement for up to $75 million common stock offering

## Summary
- Up to $75M in common stock may be sold at-the-market through agent Leerink Partners.
- Agent commission of 3.0% of gross proceeds; Company to reimburse certain expenses.
- Net proceeds to fund product candidate development, working capital, and general corporate purposes.
- Sales under existing shelf registration statement (S-3) filed March 5, 2024.

## SEC filing metadata
- accession: 0001193125-24-236782
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524236782/0001193125-24-236782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524236782/d835769d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-236782
- JSON: https://secwatch.observer/filing/0001193125-24-236782.json
- Plain text: https://secwatch.observer/filing/0001193125-24-236782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.